Literature DB >> 34878180

American Cancer Society's report on the status of cancer disparities in the United States, 2021.

Farhad Islami1, Carmen E Guerra2, Adair Minihan3, K Robin Yabroff4, Stacey A Fedewa3, Kirsten Sloan5, Tracy L Wiedt6, Blake Thomson1, Rebecca L Siegel7, Nigar Nargis8, Robert A Winn9, Lisa Lacasse10, Laura Makaroff11, Elvan C Daniels12, Alpa V Patel13, William G Cance14, Ahmedin Jemal15.   

Abstract

In this report, the authors provide comprehensive and up-to-date US data on disparities in cancer occurrence, major risk factors, and access to and utilization of preventive measures and screening by sociodemographic characteristics. They also review programs and resources that have reduced cancer disparities and provide policy recommendations to further mitigate these inequalities. The overall cancer death rate is 19% higher among Black males than among White males. Black females also have a 12% higher overall cancer death rate than their White counterparts despite having an 8% lower incidence rate. There are also substantial variations in death rates for specific cancer types and in stage at diagnosis, survival, exposure to risk factors, and receipt of preventive measures and screening by race/ethnicity, socioeconomic status, and geographic location. For example, kidney cancer death rates by sex among American Indian/Alaska Native people are ≥64% higher than the corresponding rates in each of the other racial/ethnic groups, and the 5-year relative survival for all cancers combined is 14% lower among residents of poorer counties than among residents of more affluent counties. Broad and equitable implementation of evidence-based interventions, such as increasing health insurance coverage through Medicaid expansion or other initiatives, could substantially reduce cancer disparities. However, progress will require not only equitable local, state, and federal policies but also broad interdisciplinary engagement to elevate and address fundamental social inequities and longstanding systemic racism.
© 2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.

Entities:  

Keywords:  cancer; disparity; race/ethnicity; rurality; socioeconomic status

Mesh:

Year:  2021        PMID: 34878180     DOI: 10.3322/caac.21703

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  11 in total

1.  The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.

Authors:  Ping Zhu; Guiyu Kang; Yang Jiao; Chengzhi Gui; Huiping Fan; Xiangying Li; Yanfei Jia; Lulu Zhang; Xiaoli Ma
Journal:  Hum Cell       Date:  2022-05-20       Impact factor: 4.174

2.  Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.

Authors:  Haolan Wang; Liqing Lu; Xujun Liang; Yongheng Chen
Journal:  Cancer Immunol Immunother       Date:  2021-12-02       Impact factor: 6.968

Review 3.  Motivational interviewing interventions aiming to improve health behaviors among cancer survivors: a systematic scoping review.

Authors:  Memnun Seven; Allecia Reid; Sabriye Abban; Camilla Madziar; Jamie M Faro
Journal:  J Cancer Surviv       Date:  2022-09-14       Impact factor: 4.062

4.  Association Between Residence in Historically Redlined Districts Indicative of Structural Racism and Racial and Ethnic Disparities in Breast Cancer Outcomes.

Authors:  Jesse J Plascak; Kirsten Beyer; Xinyi Xu; Antoinette M Stroup; Gabrielle Jacob; Adana A M Llanos
Journal:  JAMA Netw Open       Date:  2022-07-01

5.  Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.

Authors:  Jenny Jan; Azeez Osho; Caitlin C Murphy; Carolyn M Mazure; Amit G Singal; Nicole E Rich
Journal:  Gastroenterology       Date:  2022-03-12       Impact factor: 33.883

6.  Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?

Authors:  Fabiana Cancrini; Floriane Michel; Olivier Cussenot; Hussa Alshehhi; Eva Comperat; Véronique Phé
Journal:  World J Urol       Date:  2022-01-29       Impact factor: 3.661

7.  Polymerized β-Cyclodextrin-Based Injectable Hydrogel for Sustained Release of 5-Fluorouracil/Methotrexate Mixture in Breast Cancer Management: In Vitro and In Vivo Analytical Validations.

Authors:  Saud Almawash; Mohamed A El Hamd; Shaaban K Osman
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

8.  Trends in Cancer Mortality Among Black Individuals in the US From 1999 to 2019.

Authors:  Wayne R Lawrence; Jennifer K McGee-Avila; Jacqueline B Vo; Qianlai Luo; Yingxi Chen; Maki Inoue-Choi; Amy Berrington de González; Neal D Freedman; Meredith S Shiels
Journal:  JAMA Oncol       Date:  2022-08-01       Impact factor: 33.006

9.  A Feasible Path to Reductions in Racial and Ethnic Disparities in Lung Cancer Screening?

Authors:  Debra P Ritzwoller
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

10.  Examining the relationship between household wealth and colorectal cancer screening behaviors among U.S. men aged 45-75.

Authors:  Kevin M Korous; Adolfo G Cuevas; Jad Chahoud; Uchenna C Ogbonnaya; Ellen Brooks; Charles R Rogers
Journal:  SSM Popul Health       Date:  2022-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.